Spironolactone does not reduce the rate of cardiovascular death or heart failure in patients undergoing maintenance dialysis.

Dr Mariana Chavez MacGregor reports on advances from ASCO 2025, emphasizing treatment de-escalation and emerging tools like ctDNA for personalized care.

Two major UK cardiology trials are falling behind recruitment targets, prompting changes to entry criteria and calls for ...

Older adults typically live with multiple chronic conditions, requiring their weight loss management to be coordinated and multidisciplinary. Beverly Tchang, MD, explains why this is so important.

A new gene risk score, informed by machine learning, can predict weight-loss outcomes after Roux-en-Y gastric bypass surgery.

Low-dose colchicine therapy may not alter pericoronary adipose tissue attenuation but can help in improving plaque stability ...

A new analysis shows no clear link between paternal valproate use and harm in offspring, raising questions about the EMA ...

VA study using combined balloon cell-sampling and DNA screening found good sensitivity and negative predictive value vs ...

A low prognostic nutritional index is associated with an increased risk for 90-day mortality and adverse postoperative ...

In bloodstream infections, shorter time to positivity in blood culture is a reliable prognostic marker, associating with ...

The extent of structural lesions seen on MRI of sacroiliac joints is higher in patients with axSpA than in individuals ...

In children with allergic sensitization, each extra month of respiratory tract infection in the first 2 years of life was ...